Skip to main content
Premium Trial:

Request an Annual Quote

Genetron Health Obtains Regulatory Approval in China for NGS Instrument, Lung Cancer Panel

NEW YORK – Genetron Health, a Chinese cancer molecular profiling and sequencing technology company, said Thursday that it has received approval from the China National Medical Products Administration for a next-generation sequencing system and a kit for an eight-gene lung cancer panel.

The Genetron S2000 is a high-throughput, automated sequencer that can run two types of flow cells, with data output of 55 Gb to 1,440 Gb per run.

The lung cancer panel, which is compatible with the company's Genetron S5 sequencer and the Genetron Chef template preparation system, covers EGFR, ALK, ROS1, BRAF, KRAS, HER2, MET, and PIK3CA.

The S2000 is the second Genetron instrument to receive NMPA approval, following the S5 benchtop instrument, based on the Thermo Fisher Scientific Ion GeneStudio S5 system for targeted NGS, last year.

Genetron, based in Beijing, was founded in 2015 and focuses on cancer molecular profiling. It has diagnosis and monitoring, early screening, and development services business units.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.